Quick Answer
Iterum Therapeutics plc reported Total Revenue of $0.00 for fiscal year 2021.
Iterum Therapeutics plc Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2021 | $0.00 | — |
| 2020 | $0.00 | -100.0% |
| 2019 | $37.0K | -95.7% |
| 2018 | $869.0K | +71.1% |
| 2017 | $508.0K | — |
| 2016 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $390.0K | — | +954.1% |
| March 31, 2019 | $37.0K | -80.6% | -85.4% |
| September 30, 2018 | $254.0K | +59.7% | +37.3% |
| June 30, 2018 | $185.0K | — | -3.1% |
| March 31, 2018 | $191.0K | — | +20.1% |
| September 30, 2017 | $159.0K | — | — |
- The most recent figure is from Iterum Therapeutics plc’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 28, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: